Pricing

Log inSign up

Michael Richman

Business Advisor at TBT Pharma

Mike is the CEO of NextCure, an immunooncology immuno-oncology company he took from startup to IPO. Previously, Mr. Richman served as the President and CEO of Amplimmune, which was acquired by AstraZeneca for $500M in 2013.

Org chart

This person is not in the org chart

Teams

This person is not in any teams

Offices

This person is not in any offices

TBT Pharma

TBT Pharma is a dermatology start up re-purposing generic and off patent compounds.

Industries

Health Care, Pharmaceutical

Headquarters

Baltimore, United States

Employees

1-10

Links

Related people